ENTG stock forecast, quote, news & analysis

Key Takeaways

• ENTG has been roughly flat over the trailing 30 days—up about 0.5%—after rallying toward $167 in early October and then giving back those gains in a sharp pullback.
• The broader trend remains strongly positive, with the stock up more than 70% year to date and trading within a 52-week range of $67.97 to $186.94.
• Second-quarter results beat expectations, with net sales of $883.2 million (up 11.5% year over year), non-GAAP EPS of $0.93, and gross margin of 47.6%.
• Third-quarter results are scheduled for October 29, 2026, with consensus near $924 million in revenue and about $1.02 in adjusted EPS.
• Recent Buy initiations from Truist and Stifel signal growing Street confidence, while a forward P/E around 32 keeps valuation a central consideration.

Current Market Snapshot

Entegris shares closed near $142.90 in the most recent session, down about 1.1% on the day and leaving the market capitalization around $21.8 billion. The stock sits below its 50-day moving average of roughly $148 but remains comfortably above its 200-day moving average near $136, with a 14-day RSI near 44 indicating a pullback from overbought territory.

The last month has been unusually volatile even by the standards of a beta-heavy semiconductor name. Shares climbed from the low $140s in mid-September to an early-October peak near $167 before retreating more than 14% over the following two weeks. That round trip left the 30-day change near neutral, even as the year-to-date advance remains well into double digits.

Entegris (ENTG) Business Overview and Competitive Position

Entegris is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. Headquartered in Billerica, Massachusetts, with roughly 7,700 employees worldwide, the company operates in two segments: Materials Solutions, which provides deposition materials, CMP slurries and pads, specialty gases, and etch and clean chemistries; and Advanced Purity Solutions, which provides filtration, purification, and contamination-control products that protect wafer and chemical purity.

Roughly 75% of revenue is tied to consumables used across semiconductor manufacturing, with the remainder driven by capital-spending projects. Advanced logic represents about 40% of sales and memory about 30%, positioning Entegris to benefit as chip complexity rises at leading-edge nodes. Investors follow the stock because its materials-intensity model tends to grow content per wafer even when unit volumes are stable.

Recent Developments Driving ENTG

Fundamentals have been strengthening. In its second-quarter report, Entegris posted net sales of $883.2 million, up 11.5% year over year, with non-GAAP EPS of $0.93 and gross margin of 47.6%—the highest level since early 2022. Management cited accelerating AI-driven demand, record liquid-filtration revenue, and double-digit growth in both unit- and capex-related businesses, while raising its 2026 wafer-start growth assumption to 7%–8%.

The Street has responded constructively. Truist Securities initiated coverage with a Buy rating and a $190 price target in mid-October, while Stifel launched coverage with a Buy rating and a $200 target, projecting roughly 30% EPS growth beginning in 2027–2028. Oppenheimer and Deutsche Bank had earlier upgraded the shares. The consensus rating remains Buy, with an average price target near $179. Not all firms agree—Goldman Sachs maintains a Sell rating at a $120 target—reflecting a genuine debate about how much of the AI and capex story is already priced in.

The period also brought leadership and portfolio changes. Dave Reeder serves as President and CEO following the retirement of longtime executive chair Bertrand Loy in July, and the company has streamlined its footprint by exiting its life sciences fluid-management business and closing a Utah facility to concentrate on core semiconductor operations.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page highlights a curated selection of top-performing automated strategies. Tickeron offers hundreds of AI trading bots that trade thousands of tickers, but only the most relevant and consistently strong performers are featured in this section. The bots vary widely in strategy, timeframe, and performance metrics, so investors can compare approaches that range from short-term momentum to longer-horizon trend following. Exploring the page can help traders identify systematic strategies aligned with their own risk tolerance and objectives.

2026 Outlook and What Investors Should Watch

The most immediate catalyst is the third-quarter report scheduled for October 29, 2026. Investors will focus on whether results and forward commentary confirm the raised 2026 outlook, which calls for sequential revenue growth and mid-teens year-over-year gains in the back half of the year.

Beyond the quarter, the key themes are the multi-year fab-construction wave—management is tracking more than 20 leading-edge capacity expansions globally—and rising materials intensity at advanced nodes, including HBM4-related memory transitions and molybdenum precursor demand. Management expects these investments to contribute more meaningfully in 2027. Margin expansion, continued deleveraging toward a high-2x net leverage ratio, and progress in advanced packaging are additional watch items.

Key risks include an elevated valuation relative to peers, execution against a high-growth narrative, lingering softness in mainstream logic, and macroeconomic or trade-policy uncertainty that could affect customer spending.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations